晨间信号Morning Signal
《科学》 第393卷 第6810期 · 2026年7月30日 · 中文解读

酵母中实现抗癌必需药物依托泊苷和替尼泊苷的可持续生产

Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast · S. Shen et al.
约 87 分钟Research在小程序里点播,20 到 60 分钟做好
这篇讲什么
该研究通过在酵母中重构超过60处基因编辑和45个异源基因,实现了抗癌药物依托泊苷和替尼泊苷前体的从头生物合成,并通过单步化学转化获得这两种药物,为可持续供应链提供了新途径。
原文开头
Full article and list of author affiliations: https://doi.org/10.1126/ science.aef5438 Siyu Shen†, Xue Hu†, Dan Li†, Yuru Tong†, Yunpeng Lv, Zhenjiang Tian, Jiadian Wang, Hao Tang, Yapeng Wang, Lan Kang, Jens Nielsen, Luqi Huang*, Yating Hu* INTRODUCTION: Etoposide is an essential therapeutic agent on the World Health Organization Model List of Essential Medicines, serving as first- line treatment of several cancers, including small cell lung cancer. Its analog, teniposide, also plays a critical role in treatment of leukemia and some brain tumors. Both drugs are used to treat millions of cancer patients annually. …
摘自《科学》(Science)第393卷 第6810期 · 2026年7月30日,S. Shen et al.。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章